These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


278 related items for PubMed ID: 21697331

  • 1. Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals.
    García-Castillo M, Del Campo R, Morosini MI, Riera E, Cabot G, Willems R, van Mansfeld R, Oliver A, Cantón R.
    J Clin Microbiol; 2011 Aug; 49(8):2905-10. PubMed ID: 21697331
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology.
    Del Barrio-Tofiño E, Zamorano L, Cortes-Lara S, López-Causapé C, Sánchez-Diener I, Cabot G, Bou G, Martínez-Martínez L, Oliver A, GEMARA-SEIMC/REIPI Pseudomonas study Group.
    J Antimicrob Chemother; 2019 Jul 01; 74(7):1825-1835. PubMed ID: 30989186
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying blaVIM-2, blaVIM-1, blaIMP-8, blaVIM-20 and blaKPC-2.
    PÉrez-VÁzquez M, Sola-Campoy PJ, Zurita ÁM, Ávila A, GÓmez-Bertomeu F, SolÍs S, LÓpez-Urrutia L, GÓnzalez-BarberÁ EM, Cercenado E, Bautista V, Lara N, Aracil B, Oliver A, Campos J, Oteo-Iglesias J, Spanish Antibiotic Resistance Surveillance Program collaborating Group.
    Int J Antimicrob Agents; 2020 Jul 01; 56(1):106026. PubMed ID: 32450200
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.
    Cabot G, Ocampo-Sosa AA, Domínguez MA, Gago JF, Juan C, Tubau F, Rodríguez C, Moyà B, Peña C, Martínez-Martínez L, Oliver A, Spanish Network for Research in Infectious Diseases (REIPI).
    Antimicrob Agents Chemother; 2012 Dec 01; 56(12):6349-57. PubMed ID: 23045355
    [Abstract] [Full Text] [Related]

  • 9. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons.
    Rojo-Bezares B, Estepa V, Cebollada R, de Toro M, Somalo S, Seral C, Castillo FJ, Torres C, Sáenz Y.
    Int J Med Microbiol; 2014 May 01; 304(3-4):405-14. PubMed ID: 24594145
    [Abstract] [Full Text] [Related]

  • 10. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
    Riera E, Cabot G, Mulet X, García-Castillo M, del Campo R, Juan C, Cantón R, Oliver A.
    J Antimicrob Chemother; 2011 Sep 01; 66(9):2022-7. PubMed ID: 21653605
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The increasing threat of Pseudomonas aeruginosa high-risk clones.
    Oliver A, Mulet X, López-Causapé C, Juan C.
    Drug Resist Updat; 2015 Sep 01; 21-22():41-59. PubMed ID: 26304792
    [Abstract] [Full Text] [Related]

  • 14. Clonal Dissemination of Pseudomonas aeruginosa Sequence Type 235 Isolates Carrying blaIMP-6 and Emergence of blaGES-24 and blaIMP-10 on Novel Genomic Islands PAGI-15 and -16 in South Korea.
    Hong JS, Yoon EJ, Lee H, Jeong SH, Lee K.
    Antimicrob Agents Chemother; 2016 Dec 01; 60(12):7216-7223. PubMed ID: 27671068
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
    Gutiérrez O, Juan C, Cercenado E, Navarro F, Bouza E, Coll P, Pérez JL, Oliver A.
    Antimicrob Agents Chemother; 2007 Dec 01; 51(12):4329-35. PubMed ID: 17938181
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multilocus sequence typing reveals genetic diversity of carbapenem- or ceftazidime-nonsusceptible Pseudomonas aeruginosa in China.
    Ji J, Wang J, Zhou Z, Wang H, Jiang Y, Yu Y.
    Antimicrob Agents Chemother; 2013 Nov 01; 57(11):5697-700. PubMed ID: 23939886
    [Abstract] [Full Text] [Related]

  • 19. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.
    Castanheira M, Deshpande LM, Costello A, Davies TA, Jones RN.
    J Antimicrob Chemother; 2014 Jul 01; 69(7):1804-14. PubMed ID: 24603963
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.